Novo Integrated Sciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Novo Integrated Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q2 2024.
Novo Integrated Sciences, Inc. Operating Income (Loss) for the quarter ending May 31, 2024 was -$2.52M, a 76.2% decline year-over-year.
Novo Integrated Sciences, Inc. Operating Income (Loss) for the twelve months ending May 31, 2024 was -$10.5M, a 59.4% increase year-over-year.
Novo Integrated Sciences, Inc. annual Operating Income (Loss) for 2023 was -$8.55M, a 65.8% increase from 2022.
Novo Integrated Sciences, Inc. annual Operating Income (Loss) for 2022 was -$25M, a 472% decline from 2021.
Novo Integrated Sciences, Inc. annual Operating Income (Loss) for 2021 was -$4.37M, a 2.6% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$10.5M	-$2.52M	-$1.09M	-76.2%	Mar 1, 2024	May 31, 2024	10-Q	2024-07-19
Q1 2024	-$9.38M	-$1.54M	+$247K	+13.8%	Dec 1, 2023	Feb 29, 2024	10-Q	2024-04-15
Q4 2023	-$9.63M	-$3.32M	-$1.08M	-48%	Sep 1, 2023	Nov 30, 2023	10-Q	2024-01-22
Q3 2023	-$8.55M	-$3.09M	+$17.2M	+84.8%	Jun 1, 2023	Aug 31, 2023	10-K	2023-12-14
Q2 2023	-$25.8M	-$1.43M	-$228K	-18.9%	Mar 1, 2023	May 31, 2023	10-Q	2024-07-19
Q1 2023	-$25.6M	-$1.79M	+$334K	+15.7%	Dec 1, 2022	Feb 28, 2023	10-Q	2024-04-15
Q4 2022	-$25.9M	-$2.24M	-$878K	-64.4%	Sep 1, 2022	Nov 30, 2022	10-Q	2024-01-22
Q3 2022	-$25M	-$20.3M	-$18.5M	-977%	Jun 1, 2022	Aug 31, 2022	10-K	2023-12-14
Q2 2022	-$6.57M	-$1.2M	-$801K	-199%	Mar 1, 2022	May 31, 2022	10-Q	2023-07-17
Q1 2022	-$5.77M	-$2.12M	-$795K	-59.9%	Dec 1, 2021	Feb 28, 2022	10-Q	2023-05-26
Q4 2021	-$4.98M	-$1.36M	-$606K	-80%	Sep 1, 2021	Nov 30, 2021	10-Q	2023-05-24
Q3 2021	-$4.37M	-$1.89M	+$2.07M	+52.3%	Jun 1, 2021	Aug 31, 2021	10-K	2023-04-03
Q2 2021	-$6.44M	-$402K	-$323K	-412%	Mar 1, 2021	May 31, 2021	10-Q	2022-07-14
Q1 2021	-$6.12M	-$1.33M	-$1.18M	-779%	Dec 1, 2020	Feb 28, 2021	10-Q	2022-04-13
Q4 2020	-$4.94M	-$758K	-$681K	-886%	Sep 1, 2020	Nov 30, 2020	10-Q	2022-01-18
Q3 2020	-$4.26M	-$3.96M	-$3.53M	-823%	Jun 1, 2020	Aug 31, 2020	10-K	2021-12-14
Q2 2020	-$735K	-$78.6K	-$15.4K	-24.4%	Mar 1, 2020	May 31, 2020	10-Q	2021-07-14
Q1 2020	-$719K	-$151K	-$72.1K	-91.6%	Dec 1, 2019	Feb 29, 2020	10-Q	2021-04-14
Q4 2019	-$647K	-$76.8K	+$139K	+64.3%	Sep 1, 2019	Nov 30, 2019	10-Q	2021-01-13
Q3 2019	-$786K	-$428K	-$335K	-358%	Jun 1, 2019	Aug 31, 2019	10-K	2020-12-09
Q2 2019	-$451K	-$63.1K	+$114K	+64.3%	Mar 1, 2019	May 31, 2019	10-Q	2020-07-14
Q1 2019	-$564K	-$78.7K	+$1.05M	+93%	Dec 1, 2018	Feb 28, 2019	10-Q	2020-04-20
Q4 2018	-$1.61M	-$215K	-$43K	-24.9%	Sep 1, 2018	Nov 30, 2018	10-Q	2020-01-13
Q3 2018	-$1.57M	-$93.5K	-$131K	-347%	Jun 1, 2018	Aug 31, 2018	10-K	2019-11-20
Q2 2018	-$1.44M	-$177K	+$84K	+32.2%	Mar 1, 2018	May 31, 2018	10-Q	2019-07-11
Q1 2018	-$1.52M	-$1.13M	-$1.17M	-2494%	Dec 1, 2017	Feb 28, 2018	10-Q	2019-04-11
Q4 2017	-$348K	-$172K	-$235K	-374%	Sep 1, 2017	Nov 30, 2017	10-Q	2019-01-11
Q3 2017	-$113K	$37.9K			Jun 1, 2017	Aug 31, 2017	10-K	2018-11-06
Q2 2017		-$261K	-$318K	-555%	Mar 1, 2017	May 31, 2017	10-Q	2018-07-11
Q1 2017		$47.1K			Dec 1, 2016	Feb 28, 2017	10-Q	2018-04-12
Q4 2016		$62.9K			Sep 1, 2016	Nov 30, 2016	10-Q	2018-01-12
Q2 2016		$57.4K			Mar 1, 2016	May 31, 2016	10-Q	2017-07-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.